Akturk, Halis Kaan <br/><br/>
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  10 2018 
 - 3589-3592 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2018-01430  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Autoimmunity--drug effects<br/>Diabetes Mellitus, Type 1--chemically induced<br/>Graft Rejection--etiology<br/>Humans<br/>Immunotherapy--adverse effects<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Skin Neoplasms--drug therapy